SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-151728
Filing Date
2024-05-31
Accepted
2024-05-31 16:05:59
Documents
18
Period of Report
2024-05-31
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d781980d8k.htm   iXBRL 8-K 29792
2 EX-99.1 d781980dex991.htm EX-99.1 12793
7 GRAPHIC g781980dsp001.jpg GRAPHIC 11106
8 GRAPHIC g781980dsp001a.jpg GRAPHIC 9643
9 GRAPHIC g781980dsp001b.jpg GRAPHIC 6313
  Complete submission text file 0001193125-24-151728.txt   245601

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA dbvt-20240531.xsd EX-101.SCH 3101
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dbvt-20240531_def.xml EX-101.DEF 13867
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE dbvt-20240531_lab.xml EX-101.LAB 22898
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dbvt-20240531_pre.xml EX-101.PRE 14705
21 EXTRACTED XBRL INSTANCE DOCUMENT d781980d8k_htm.xml XML 5898
Mailing Address 107 AVENUE DE LA REPUBLIQUE CHATILLON I0 92320
Business Address 107 AVENUE DE LA REPUBLIQUE CHATILLON I0 92320 33(0)155427878
DBV Technologies S.A. (Filer) CIK: 0001613780 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36697 | Film No.: 241009655
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)